Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PRVA
PRVA logo

PRVA Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
21.240
Open
21.240
VWAP
21.04
Vol
746.23K
Mkt Cap
2.60B
Low
20.850
Amount
15.70M
EV/EBITDA(TTM)
41.01
Total Shares
123.69M
EV
2.24B
EV/OCF(TTM)
13.68
P/S(TTM)
1.31
Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.
Show More

Events Timeline

(ET)
2026-02-26
06:30:00
Company Reports Q4 Revenue of $541.2M
select
2026-02-26
06:30:00
Expects Approximately $600M in Cash by Year-End 2026
select

News

NASDAQ.COM
5.0
03-22NASDAQ.COM
Privia Health CFO Sells Shares for Tax Obligations
  • Executive Stock Sale: David Mountcastle, CFO of Privia Health, sold 13,018 shares between March 12 and 13, 2026, for approximately $283,000 at an average price of $21.71 per share, representing 5.24% of his total direct holdings.
  • Tax Obligation Reason: The sale was strictly for tax withholding obligations related to the vesting of performance stock units, indicating that investors should not interpret this transaction as a negative signal for PRVA stock, but rather focus on the company's fundamentals.
  • Strong Financial Performance: Despite a 10% decline in PRVA's stock price in 2026, the company exceeded earnings expectations in its Q4 FY 2025 report, posting 7 cents per share, surpassing the 4-cent estimate and marking the highest year-over-year growth since Q3 2023.
  • Market Expansion Potential: Privia's acquisition of an Accountable Care Organization in late September 2025 added approximately 1.5 million customers, showcasing the company's growth potential in value-based operations, although analysts remain cautious about its future performance.
Fool
5.0
03-22Fool
Privia Health CFO Sells Shares for Tax Obligations
  • Transaction Overview: Privia Health CFO David Mountcastle sold 13,018 shares on March 12 and 13, 2026, for approximately $283,000, indicating a necessary action for tax obligations related to stock vesting.
  • Ownership Percentage Change: This transaction reduced Mountcastle's direct holdings by 5.24%, leaving him with 226,804 shares directly held, which represents a 0.18% stake in the company's outstanding shares, reflecting changes in ownership structure.
  • Stable Financial Performance: Despite a 10.15% decline in PRVA stock in 2026, the company exceeded earnings expectations in its Q4 FY 2025 report, posting earnings of $0.07 per share, significantly above the $0.04 estimate, demonstrating resilience in its fundamentals.
  • Customer Base Expansion: By acquiring an Accountable Care Organization (ACO), Privia gained approximately 1.5 million customers with medical plans such as Medicare, Medicare Advantage, and Medicaid, indicating growth potential in its value-based operations.
Yahoo Finance
5.0
03-22Yahoo Finance
Privia Health CFO Sells $283,000 Worth of Shares to Cover Taxes
  • Transaction Overview: David Mountcastle, CFO of Privia Health Group, sold 13,018 shares between March 12 and 13, 2026, for approximately $283,000, indicating a liquidity move to cover tax obligations.
  • Ownership Impact: This sale reduced Mountcastle's direct holdings by 5.24%, leaving him with 226,804 shares and a mere 0.18% stake in the company, which may raise concerns about management stability among investors.
  • Financial Context: Despite a 10.15% decline in PRVA's stock price in 2026, the company reported strong Q4 FY 2025 earnings, posting 7 cents per share, exceeding the 4-cent estimate, showcasing financial resilience.
  • Market Reaction Advice: As the share sale was strictly for tax withholding related to the vesting of performance stock units, investors should not interpret this transaction negatively, especially given the company's acquisition of 1.5 million customers through an Accountable Care Organization, indicating potential for future growth.
NASDAQ.COM
8.5
03-05NASDAQ.COM
BlackBarn Capital Increases Warby Parker Stake by 2 Million Shares
  • Stake Increase: BlackBarn Capital increased its stake in Warby Parker by 2 million shares during Q4 2025, with an estimated transaction value of $43.52 million, indicating confidence in the company despite a 15% decline in its stock price over the past year.
  • Value Appreciation: The value of Warby Parker's position rose by $37.79 million at quarter-end, reflecting the impact of trading activity and stock price fluctuations, suggesting that BlackBarn Capital's investment strategy is proving effective.
  • Asset Allocation Shift: Following the increase, Warby Parker now accounts for 4.3% of BlackBarn Capital's 13F reportable assets, indicating its significance in the investment portfolio, even though it does not rank among the top five holdings.
  • Market Performance Insight: As of February 13, 2026, Warby Parker shares were priced at $22.46, underperforming the S&P 500 by 26.8 percentage points, prompting investors to monitor the company's ability to achieve sustainable growth in the optical retail market.
Fool
8.5
03-05Fool
BlackBarn Capital Increases Warby Parker Stake to 3 Million Shares
  • Share Increase: According to a recent SEC filing dated February 17, 2026, BlackBarn Capital Partners LP acquired an additional 2 million shares of Warby Parker, raising its total stake to 3 million shares, with an estimated transaction value of $43.52 million, reflecting confidence in the company's growth potential.
  • Asset Management Proportion: Warby Parker now accounts for 4.3% of BlackBarn Capital's reportable assets under management, indicating its significance in the firm's 13F report and investor recognition of its potential value.
  • Market Performance: As of February 13, 2026, Warby Parker shares were priced at $22.46, down 15% over the past year and underperforming the S&P 500 by 26.8 percentage points, highlighting market concerns regarding its future growth.
  • Business Model Analysis: Warby Parker challenges traditional eyewear retail economics through a direct-to-consumer model, and while facing high costs and competitive pressures, its expanding exam capacity may ultimately be key to its future profitability.
Newsfilter
8.5
03-03Newsfilter
EHR-Enabled Colorectal Cancer Screening Achieves Significant Impact
  • Screening Rate Increase: The colorectal cancer screening program led by Privia Health achieved an 84% screening rate in 2024, surpassing national benchmarks and the National Colorectal Cancer Roundtable's 80% goal, demonstrating the effectiveness of data-driven patient engagement models.
  • Patient Engagement Scale: The program successfully engaged over 42,000 patients through automated outreach, with plans to expand nationally to over 100,000 patients, significantly enhancing the reach and efficiency of screenings.
  • Diagnostic Follow-Up Rate: Within a 48-hour window, approximately 23,000 screening orders were processed, yielding a 10% positivity rate that identified over 550 patients requiring further diagnostic follow-up, indicating the program's potential in early cancer detection.
  • Support for Value-Based Care: The initiative not only improved screening outcomes but also strengthened patient identification and documentation quality, supporting electronic clinical quality measure (eCQM) reporting and positioning health systems to meet future digital quality measurement requirements.
Wall Street analysts forecast PRVA stock price to rise
12 Analyst Rating
Wall Street analysts forecast PRVA stock price to rise
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
23.00
Averages
30.40
High
34.00
Current: 0.000
sliders
Low
23.00
Averages
30.40
High
34.00
Barclays
Equal Weight
maintain
$23 -> $25
AI Analysis
2026-03-25
New
Reason
Barclays
Price Target
$23 -> $25
AI Analysis
2026-03-25
New
maintain
Equal Weight
Reason
Barclays raised the firm's price target on Privia Health to $25 from $23 and keeps an Equal Weight rating on the shares. The firm revised models in the healthcare facilities and managed care group following the Q4 reports.
JPMorgan
Overweight
maintain
$33 -> $35
2026-03-07
Reason
JPMorgan
Price Target
$33 -> $35
2026-03-07
maintain
Overweight
Reason
JPMorgan raised the firm's price target on Privia Health to $35 from $33 and keeps an Overweight rating on the shares. The firm views the company's Q4 report as solid. It increased estimates post the print.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PRVA
Unlock Now

Valuation Metrics

The current forward P/E ratio for Privia Health Group Inc (PRVA.O) is 90.75, compared to its 5-year average forward P/E of 47.75. For a more detailed relative valuation and DCF analysis to assess Privia Health Group Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
47.75
Current PE
90.75
Overvalued PE
346.70
Undervalued PE
-251.19

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
36.79
Current EV/EBITDA
19.26
Overvalued EV/EBITDA
57.66
Undervalued EV/EBITDA
15.93

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.94
Current PS
1.29
Overvalued PS
2.83
Undervalued PS
1.06

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what is good stock to day trade today
Intellectia · 36 candidates
Price: $5.00 - $80.00Price Change Pct: $3.00 - $15.00Relative Vol: >= 1.50Beta: HighRiskList Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 2,000,000
Ticker
Name
Market Cap$
top bottom
BSY logo
BSY
Bentley Systems Inc
11.64B
FIGS logo
FIGS
Figs Inc
2.05B
MGNI logo
MGNI
Magnite Inc
1.95B
CRSP logo
CRSP
CRISPR Therapeutics AG
5.93B
WWW logo
WWW
Wolverine World Wide Inc
1.64B
ARHS logo
ARHS
Arhaus Inc
1.31B
what about health tech stocks and robots?
Intellectia · 18 candidates
Market Cap: 50.00M - 50.00BWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ROK logo
ROK
Rockwell Automation Inc
47.26B
SYM logo
SYM
Symbotic Inc
36.98B
TER logo
TER
Teradyne Inc
36.32B
VEEV logo
VEEV
Veeva Systems Inc
36.12B
ZBRA logo
ZBRA
Zebra Technologies Corp
12.31B
DOCS logo
DOCS
Doximity Inc
7.50B

Whales Holding PRVA

V
Van Berkom and Associates Inc.
Holding
PRVA
+0.43%
3M Return
R
Riverbridge Partners, LLC
Holding
PRVA
-9.78%
3M Return
D
Durable Capital Partners, LP
Holding
PRVA
-12.09%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Privia Health Group Inc (PRVA) stock price today?

The current price of PRVA is 21.03 USD — it has decreased -2.28

What is Privia Health Group Inc (PRVA)'s business?

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

What is the price predicton of PRVA Stock?

Wall Street analysts forecast PRVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRVA is30.40 USD with a low forecast of 23.00 USD and a high forecast of 34.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Privia Health Group Inc (PRVA)'s revenue for the last quarter?

Privia Health Group Inc revenue for the last quarter amounts to 541.17M USD, increased 17.42

What is Privia Health Group Inc (PRVA)'s earnings per share (EPS) for the last quarter?

Privia Health Group Inc. EPS for the last quarter amounts to 0.07 USD, increased 133.33

How many employees does Privia Health Group Inc (PRVA). have?

Privia Health Group Inc (PRVA) has 1226 emplpoyees as of March 25 2026.

What is Privia Health Group Inc (PRVA) market cap?

Today PRVA has the market capitalization of 2.60B USD.